Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
33
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Impact of Early Response to Sequential High-dose Chemotherapy on Outcome of Patients With Advanced Myeloma and Poor Prognostic Features

Ruben Niesvizky New York Presbyterian Hospital, Weill Medical College of Cornell University, 520 East 70th Street, Starr 341, New York, NY 10021, USA
,
David Siegel Carol Simon Cancer Center, 100 Madison Avenue, PO Box 1089, Morristown, NJ 07962, USA
,
Jill Glassman Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
,
David Straus Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
,
Jacqueline Fine 3720 Blackstone Ave, Riverdale, NY 10463, USA
,
Larry Lyons New York Presbyterian Hospital, Weill Medical College of Cornell University, 520 East 70th Street, Starr 341, New York, NY 10021, USA
&
Joseph Michaeli New York Presbyterian Hospital, Weill Medical College of Cornell University, 520 East 70th Street, Starr 341, New York, NY 10021, USA
 show all
Pages 607-612 | Published online: 01 Jul 2009

  • Jagannath, S., Barlogie, B., Dicke, K., Alexanian, R., Zagars, G., Cheson, B., Lemaistre, F.C., Smallwood, L., Pruitt, K. and Dixon, D.O. (1990) "Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors", Blood 76, 1860-1866
  • Dalton, W.S. and Salmon, S.E. (1912) "Drug resistance in myeloma: mechanisms and approaches to circumvention", Hematol/Onrol, Clin. N. Am. 6, 383-393.
  • Barlogie, S., Smith, L. and Alexanian, R. (1984) "Effective treatment of advanced multiple myeloma refractory to alkylating agents", N. Engl. J. Med. 310, 1353-1356.
  • Durie, B.G., Dixon, D.O., Carter, S., Stephens, R., Rivkin, S., Bonnet, J., Salmon, S.E., Dabich, L., Files, J.C. and Coslanzi, J.J. (1986) "Improved survival duration with combination chemotherapy induction for multiple myeloma: a southwest oncology group study", J. Clin. Oncol 4, 1227-1237
  • Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", JASA 53, 457.
  • Collett, D. (1994) Modelling Survival Data in Medical Research, (Chapman and Hall, London), Chapter 3.
  • Heller, G. and Simonoff, J.S. (1992) "Prediction in censored survival data: a comparison of the proportional hazards and linear regression models", Biometrics 48, 101-115.
  • Samson, D., Gaminara, E., Newland, A., Van de Pette, J, Kearney, J., McCarthy, D., Joyner, M., Aston, L., Mitchell, T., Hamon, M. and Evans, M. (1989) "Infusion of vineristine and doxorubicin with oral dexamethasone as first line therapy for multiple myeloma", Lancet 2(8668), 882-885.
  • Grosbois, B., Menard, J.B., Leloet, X., Bernard, J.F., Michaux, J.L. and Monconduit, M. (1990) "Complete remission in multiple myeloma", Lancet 335, 52-53.
  • MacLennan, I.C.M. and Cusick, J. (1985) "Objective evaluation of the role of Vineristine in induction and maintenance therapy for myelomatosis", Br. J Cancer 52, 153-158.
  • Cornwell, G.G., Pajak, T.F., Kochwa, S., Mclntyre, O.R., Glowienka, L.P. Brunner, K., Rafla, S., Silver, R.T., Cooper, M.R., Henderson, E., Kyle, R.A., Haurani, F.I. and Cuttner, J. (1982) "Comparison of oral melphalan, CCNU, and BCNU with and without vineristine and prednisone in the treatment of multiple myeloma", Cancer 50(9), 1669-1675.
  • Jackson, D.V., Case. L.D., Pope, E.K., White, D.R., Spurr, C.L., Richards, F. Stuart, J.J., Muss, H.B., Cooper, M.R. and Black, W.R. (1985) "Single agent vincristine by infusion in refractory multiple myeloma", J. Clin. Oncol. 3(11), 1508-1512.
  • Alexanian, R., Barlogie, B. and Dixon, D. (1986) "High-dose glucocoticoid treatment of resistant myeloma", Ann. Intern. Med. 105(1), 8-11.
  • Alexanian, R., Barlogic, B. and Tucker, S. (1990) "VAD-based regimens as primary treatment for multiple myeloma", Am. J. Hematol. 33(2). 86-89.
  • Hansen, O.P., Jessen, B. and Vidrbae, K. (1973) "Prognosis of myelomatosis on treatment with prednisone and cytostaties", Scand. J. Haematol. 10, 282-290.
  • Hobbs, J.R (1969) "Growth rates and responses to treatment in human myelomatosis", Br. J. Haematol. 16, 607-617.
  • Kyle, R.A. (1983) "Long term survival in multiple myeloma", N. Engl. J. Med. 308, 314-316.
  • Boccadoro, M., Marmout, E. Tribalto, M., Fassati, G., Redoglia, V., Battaglio, S., Massaia, M., Gallamini, A., Comotti, B., Barbui, T., Campobasso, N., Dammacco, R. Cantonetti, M., Petrucci, M.T., Mandelli, F., Resegotti, L. and Pileri, A. (1989) "Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis", J. Clin. Oncol. 7, 119-125.
  • Goldie, J.H. and Coldman, A.J. (1979) "A mathematical model for relating drug sensitivity of tumors to their spontaneous mutation rate", Cancer Treat. Rep. 63, 1727-1733.
  • Norton, L. and Simon, R. (1986) "The Norton-Simon hypothesis revisited", Cancer Treat. Rep. 70, 163-169.
  • Lennard, Jr, R.E., Oken, M.M. and Barnes, J.M. (1984) "High-dose cyclophosphamide: an effective treatment for advanced refractory multiple myeloma", Cancer 53. 1456.
  • Greipp, P.R., Leong, T., Bennett, J.M., Gaillard, J.P., Klein, B., Stewart, J.A., Oken, M.M., Kay, N.B., VanNess, B. and Kyle, R.A. (1998) "Plasmablastic morphology--an independentprognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group", Blood 91, 2501-2507.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.